DBVT (STOCKS)
DBV Technologies S.A.
$14.030000
-0.110000 (-0.78%)
Prev close: $14.140000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Daniel Tassé
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $916.00M
- Employees
- 117
- P/E (TTM)
- -3.99
- P/B (TTM)
- 5.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.64M |
| Benefits Costs and Expenses | $152.09M |
| Costs And Expenses | $152.09M |
| Operating Expenses | $152.69M |
| Research and Development | $116.68M |
| Other Operating Expenses | $36.01M |
| Operating Income/Loss | -$147.06M |
| Other Operating Income/Expenses | $0.00 |
| Income/Loss From Continuing Operations After Tax | -$146.95M |
| Income/Loss From Continuing Operations Before Tax | -$146.46M |
| Income Tax Expense/Benefit | $491.00K |
| Income Tax Expense/Benefit, Current | $491.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$146.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$146.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$146.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.05 |
| Diluted Earnings Per Share | -$1.05 |
| Basic Average Shares | 139,574,259 |
| Diluted Average Shares | 139,574,259 |
| Assets | $233.72M |
| Current Assets | $212.94M |
| Prepaid Expenses | $2.63M |
| Other Current Assets | $210.32M |
| Noncurrent Assets | $20.78M |
| Fixed Assets | $10.37M |
| Intangible Assets | $22.00K |
| Other Non-current Assets | $10.38M |
| Liabilities | $64.95M |
| Current Liabilities | $58.03M |
| Noncurrent Liabilities | $6.92M |
| Equity | $168.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $168.77M |
| Liabilities And Equity | $233.72M |
| Net Cash Flow From Operating Activities | -$121.18M |
| Net Cash Flow From Operating Activities, Continuing | -$121.18M |
| Net Cash Flow From Investing Activities | -$1.37M |
| Net Cash Flow From Investing Activities, Continuing | -$1.37M |
| Net Cash Flow From Financing Activities | $276.18M |
| Net Cash Flow From Financing Activities, Continuing | $276.18M |
| Net Cash Flow | $153.63M |
| Net Cash Flow, Continuing | $153.63M |
| Comprehensive Income/Loss | -$140.19M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$140.19M |
| Other Comprehensive Income/Loss | $6.76M |